Shamriz O, Simon AJ, Lev A, Megged O, et al. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation. Clin Exp Immunol 2020;200:215-227.
PMID: 32201938